Aries Fund seeks to capitalize on bear market

Just when it seems that everyone wants to get out of biotech, along come the contrarians. Lindsay Rosenwald, who heads up The Castle Group and Paramount Capital, is starting The Aries Fund, a private investment trust that will focus on the investment opportunities presented by the bear

Read the full 470 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE